MINITEC
LOE ApproachingNDAINJECTION, ORALSOLUTION
Approved
Jun 1974
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 22h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MINITEC is an injection and oral solution approved in 1974 by Bracco with unknown mechanism of action and indication profile. The drug's exact therapeutic target and patient population cannot be determined from available data.
LOE Approaching
A 50-year-old product approaching loss of exclusivity signals a mature, likely consolidating team facing rapid revenue erosion and potential divestiture or discontinuation.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Zero linked job openings indicate minimal hiring momentum; MINITEC is a legacy asset with limited career growth potential. Roles available are primarily defensive commercial functions managing decline toward LOE.
Brand ManagerField Sales Representative
Worked on MINITEC at Bracco? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.